Unveiling the global research status and intellectual map of cancer and immunosuppressants
The growing body of research on cancer and immunosuppressants highlights the need for optimizing immunotherapy protocols, managing drug resistance, and exploring the potential of immunosuppressants in cancer treatment. Strengthening international collaboration is vital for translating research findings into clinical practice and improving patient outcomes. Despite the comprehensive analysis, the study's reliance on the WoSCC database and English-language publications may limit the generalizability of findings.
Authors
- Haiyuan Shi
- Yue Ben
- Jiang Gu (ORCID: https://orcid.org/0000-0002-0706-8329)
- Jun Pu (ORCID: https://orcid.org/0009-0006-0478-4246)
- Yamin Zhao
- Ye Ma (ORCID: https://orcid.org/0000-0002-3460-713X)
- Tao Wu (ORCID: https://orcid.org/0000-0001-9456-4082)
- Tianyi Yuan
Institutions
- Nantong University (CN)
- Kunming Medical University (CN)
- Affiliated Hospital of Nantong University (CN)
- Second People's Hospital of NanTong (CN)
- Yan'an Hospital Affiliated To Kunming Medical University (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2025-10-21
- DOI
- https://doi.org/10.1007/s12672-025-03781-9
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Nantong Science and Technology Bureau